Weekly Deal Watch: Cannabis investing & M&A highlights – Sept. 14, 2018

This weekly collection from Marijuana Business Daily and Viridian Capital Advisors supplies the newest knowledge on hashish funding exercise and M&A, together with key takeaways, evaluation and developments based mostly on current market strikes.

The knowledge under, offered by Viridian Capital Advisors, is thru the week ended Sept. 14, 2018.

Capital raises key takeaways: 

  • Multistate hashish retailer Have a Heart inked a $25 million increase to fund its enlargement plans. The deal underscores continued excessive curiosity from buyers in operators which have rising portfolios in a number of states, stated Scott Greiper, president of Viridian Capital Advisors. “These multistate operators provide investors diversification in their holdings and allow operators greater potential to scale through their brands,” he stated. “This is critical because in the U.S. there is no interstate commerce allowed with cannabis, but if you’re an operator that has licenses in (a number of states), you can position your scale up through branded licensing agreements.”
  • Khiron Life Sciences raised 12.9 million Canadian dollars ($9.9 million) to increase its Colombian operations, a sign that buyers are desirous about companies properly positioned for low-value hashish manufacturing. “It is widely thought that Columbia, Uruguay and other countries in that region – because of the optimal growing conditions – will become the lowest-cost producers of cannabis in the world,” Greiper stated.
  • Hyasynth Biologicals raised CA$5 million from Canadian licensed hashish producer Organigram to scale up its patent-pending course of for cannabinoid manufacturing from yeast. The deal is one other robust indicator of curiosity in low-value CBD preparations. “It’s really become a race with science rather than how many plants you get into the ground,” Greiper stated.


M&A key takeaways: 

  • Aurora Cannabis acquired two European hemp corporations, Agropro UAB and Borela UAB, the newest within the development involving Canadian licensed producers increasing into worldwide markets. “This is a major trend that’s being enabled by the ridiculous amount of capital these (Canadian producers) have been able to raise,” Greiper stated. “They’re taking their healthy cash balance sheets and stock and entering (international markets) to establish early first-mover advantages. No one can outspend these guys right now.”
  • Investment group Captor Capital acquired California marijuana corporations Mellow Extracts and Chai Cannabis – a sign of elevated funding exercise into MJ manufacturers and infused merchandise. “Cannabis is really starting to segment itself as a consumer products market, but brands in this industry remain so fragmented,” Greiper stated. “There is no major brand – no Coca-Cola or Marlboro or Grey Goose at this point, which is a huge opportunity.” Watch for extra curiosity in buying and constructing manufacturers on this area.
  • Canadian medical hashish clinic firm National Access Cannabis Corp. acquired Canadian grownup-use retailer The Green Company. The deal highlights a shift in technique for medical hashish clinic operators which are working to transition into Canada’s upcoming grownup-use market by increasing into the licensed retail phase.

Viridian Capital Advisors is a monetary and strategic advisory agency that gives funding banking, M&A, company improvement and investor relations providers to rising progress corporations and certified buyers within the hashish sector.

Categories: Canada Marijuana News, Featured, International Marijuana Business News, Marijuana Industry Data and Charts, Marijuana Stocks & Public Companies, Sales, Funding & Banking News, United States


Be the first to comment

Leave a Reply

Your email address will not be published.